Resources

Drug services professional

Around half of current injecting drug users will have hepatitis C, although this prevalence rate varies across the country.  Find here tools, resources and other relevant documents to help drugs service staff raise awareness of hepatitis C amongst service users, and improve testing and access to care.

Showing 1 to 10 of 160 resources

  • HCV Action and PHE hepatitis C roadshow in Leeds: Presentations
    On 6th September 2017, HCV Action and Public Health England (PHE) staged a hepatitis C good practice roadshow in Leeds. The event was designed to showcase and share best practice in the prevention, diagnosis, testing and treatment of hepatitis C, and identify specific issues and potential solutions for tackling hepatitis C in Leeds and the wider West Yorkshire region.
    UK, England, Yorkshire and the Humber Other, Strategy & Planning PDF
  • Good practice case study: Oxford Liaison Service outreach
    This HCV Action good practice case study looks at the community outreach work done by Oxford University Hospitals NHS Foundation Trust. A survey of injecting drug users in the Oxfordshire area to determine levels of hepatitis C testing found that a third of responders had never been tested for hepatitis C. Following the survey results, the Trust established a Liaison Service, training substance misuse staff to test clients for hepatitis C, referring patients to secondary care and, in some cases, treating patients in the community.
    UK, South East Case study PDF
  • Road to Elimination: Barriers and Best Practices in Hepatitis C Management
    This report provides an overview of the status of HCV care in Europe and Australia. Through literature review and country experts’ consultation conducted between November 2016 and March 2017, the report analyses the status of 11 countries, identifying and comparing key success factors and main barriers for each step of the HCV care cascade: (1) awareness and prevention; (2) testing and diagnosis; (3) linkage to care and access to qualified health services; (4) access to medication; and (5) monitoring and evaluation.
    UK, Rest of World Reports & Research, Strategy & Planning PDF
  • Unlinked anonymous HIV and viral hepatitis monitoring among PWID: 2017 report
    This report presents an overview of the trends between 2006 and 2016 for HIV, hepatitis B, hepatitis C and risk behaviours from the ongoing Unlinked Anonymous Monitoring Survey, which is targeted at people who inject psychoactive drugs, such as heroin, crack cocaine and amphetamines.
    UK Reports & Research PDF
  • Hepatitis C in the UK 2017 report
    The ninth Hepatitis C in the UK report follows the WHO Global Health Sector Strategy (GHSS) on Viral Hepatitis 2016-2021 and the draft action plan for the health sector response to viral hepatitis in the WHO European region. The report is structured to support UK monitoring of the GHSS goals and summarises the impact of UK action plans to drive down mortality from HCV and reduce the number of new infections.
    UK Reports & Research, Strategy & Planning PDF
  • Financial case for action on liver disease
    This report, produced by the Foundation for Liver Research and endorsed by the Lancet Commission on Liver Disease, examines the financial costs of viral hepatitis, along with alcohol misuse and obesity. The report also carries recommendations, which include improving access to testing for hepatitis C and protecting harm reduction services such as needle exchange and opioid substitution for injecting drug users.
    UK Reports & Research PDF
  • Summary report: North East & Cumbria ODN Workshop, Newcastle
    This report provides a summary of the North East & Cumbria ODN Workshop held by HCV Action, in partnership with the ODN, in Newcastle on Wednesday 3rd May 2017. The workshop brought together a range of stakeholders working across the hepatitis C pathway in the North East & Cumbria ODN region, with the aim of discussing some of the barriers faced by the ODN, as well as providing a forum in which to develop solutions to some of these challenges. The report includes summaries of the day's talks and group discussion, as well as suggested next steps to be taken following the event.
    North East, UK Reports & Research PDF
  • Good practice case study: Ipswich NHS Trust prison in-reach
    In August 2015, Ipswich NHS Trust launched an in-reach treatment service in four prisons, seeking to increase the number of inmates receiving treatment for hepatitis C. Despite a number of challenges, clear pathways have been established for engaging patients into treatment, which has resulted in a substantial increase in the number of prisoners being treated for the virus.
    UK, England, East of England Case study PDF
  • NICE Quality Standard on Liver Disease
    This NICE quality standard covers identifying, assessing and managing chronic liver disease in children, young people and adults, and cirrhosis in young people and adults. It describes high-quality care in priority areas for improvement.
    UK, England Jun 2017 Other, Strategy & Planning PDF
  • Summary report: Hepatitis C good practice roadshow, Cambridge
    This report provides a summary of the good practice hepatitis C roadshow held by HCV Action and Public Health England in Cambridge on 9th May 2017. The roadshow was aimed at sharing good practice around hepatitis C and instigating local action to address the virus. The report includes summaries of the talks and workshops held on the day, as well as attendees' pledges for taking further action on hepatitis C.
    UK, England, East of England Reports & Research PDF

Pages